VEN+IDAC vs IDAC in AML

Clinical trial NCT07537257 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07537257
Sponsor: Guangdong Second Provincial General Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

AML (Acute Myelogenous Leukemia)

Start date: 2026-04-01
Primary completion: 2027-04-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.